Abbott Laboratories
US ˙ NYSE ˙ US0028241000

SecurityABT / Abbott Laboratories
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership1,367 shares
Latest Disclosed Value $ 185,925
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 4.14% decrease in ownership of ABT / Abbott Laboratories

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 1,367 shares of Abbott Laboratories (US:ABT) valued at $185,926 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 1,426 shares of Abbott Laboratories. This represents a change in shares of -4.14% during the quarter. The current value of the position is $124,493 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Abbott Laboratories EC US0028241000 1,367 -59 -4.14 186 -2.12 0.2739
2025-05-27 2025-03-31 NP Abbott Laboratories EC US0028241000 1,426 -46 -3.12 189 13.86 0.2850
2025-02-26 2024-12-31 NP Abbott Laboratories EC US0028241000 1,472 -99 -6.30 166 -7.26 0.2382
2024-11-25 2024-09-30 NP Abbott Laboratories EC US0028241000 1,571 -42 -2.60 179 7.19 0.2470
2024-08-26 2024-06-30 NP Abbott Laboratories EC US0028241000 1,613 -35 -2.12 168 -10.70 0.2401
2024-05-28 2024-03-31 NP Abbott Laboratories EC US0028241000 1,648 -89 -5.12 187 -2.09 0.2685
2024-02-28 2023-12-31 NP Abbott Laboratories EC US0028241000 1,737 -42 -2.36 191 11.05 0.2867
2023-11-22 2023-09-30 NP Abbott Laboratories EC US0028241000 1,779 -208 -10.47 172 -20.37 0.2771
2023-08-28 2023-06-30 NP Abbott Laboratories EC US0028241000 1,987 4 0.20 217 8.00 0.3267
2023-05-25 2023-03-31 NP Abbott Laboratories EC US0028241000 1,983 -40 -1.98 201 -9.91 0.3114
2023-02-24 2022-12-31 NP Abbott Laboratories EC US0028241000 2,023 -46 -2.22 222 11.00 0.3550
2022-11-29 2022-09-30 NP ABBOTT LABORATORIES EC US0028241000 2,069 -52 -2.45 200 -13.04 0.3266
2022-08-29 2022-06-30 NP ABBOTT LABORATORIES EC US0028241000 2,121 -66 -3.02 230 -10.85 0.3508
2022-05-31 2022-03-31 NP ABBOTT LABORATORIES EC US0028241000 2,187 -63 -2.80 259 -18.35 0.3387
2022-02-28 2021-12-31 NP ABBOTT LABORATORIES EC US0028241000 2,250 -86 -3.68 317 14.91 0.3809
2021-11-24 2021-09-30 NP ABBOTT LABORATORIES EC US0028241000 2,336 -107 -4.38 276 -2.83 0.3429
2021-08-27 2021-06-30 NP ABBOTT LABORATORIES EC US0028241000 2,443 -125 -4.87 283 -7.82 0.3455
2021-06-01 2021-03-31 NP ABBOTT LABORATORIES EC US0028241000 2,568 -146 -5.38 308 3.37 0.3879
2021-03-01 2020-12-31 NP ABBOTT LABORATORIES EC US0028241000 2,714 -166 -5.76 297 -5.11 0.3770
2020-11-25 2020-09-30 NP ABBOTT LABORATORIES EC US0028241000 2,880 -112 -3.74 313 14.65 0.4206
2020-08-28 2020-06-30 NP ABBOTT LABORATORIES EC US0028241000 2,992 147 5.17 274 21.88 0.3841
2020-05-28 2020-03-31 NP ABBOTT LABORATORIES EC US0028241000 2,845 -63 -2.17 224 -11.11 0.3513
2020-02-28 2019-12-31 NP ABBOTT LABORATORIES EC 002824100 2,908 -183 -5.92 253 -2.33 0.3496
2019-11-26 2019-09-30 NP ABBOTT LABORATORIES EC US0028241000 3,091 3,091 259 0.3582
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.